UTHR
UNITED THERAPEUTICS Corp
NASDAQ · Healthcare · Biotechnology · US
$494.63
−0.53%Forward multiples
Based on analyst estimates
- P/E forward
- 19.12x
- P/E 2026E
- 18.93x
- P/E 2027E
- 17.09x
- P/E 2028E
- 14.24x
- P/S forward
- 6.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.36x
- PEG TTM
- 0.78x
- Price / book
- 3.31x
- Price / sales
- 6.73x
- Price / cash flow
- 12.59x
Enterprise value
- Enterprise value
- $18.6B
- EV / sales
- 5.88x
- EV / EBITDA
- 11.23x
- EV / EBIT
- 13.22x
- Market cap
- $21.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026